TGFB1 and neoplasm: While the mechanisms involved in the enrichment of Tregs in tumors are still not well understood, We and other investigators have recently demonstrated that tumor cells can serve as a source of TGF-β1, which is required for the induction and maintenance of Tregs in vitro and in vivo[28], [29], [30].